MOLLY MCCARTY: Open Payments
NPI 1770863292 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 77 payments from 15 companies in 2025. Trend: 2023 $258 · 2024 $1,429 · 2025 $1,393
Food & beverage: $1,247Education: $146
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $251 |
| Janssen Biotech, Inc. | 13 | $232 |
| Regeneron Healthcare Solutions, Inc. | 10 | $211 |
| ABBVIE INC. | 10 | $171 |
| UCB, Inc. | 9 | $170 |
| Amgen Inc. | 7 | $137 |
| Galderma Laboratories, L.P. | 4 | $80 |
| Lilly USA, LLC | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| LEO Pharma Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Bimzelx, OTEZLA, RINVOQ, NEMLUVIO, SKYRIZI.
Industry payments across IL — which companies pay providers there.
